DIA CHINA 2025

Event description:

Date: May 22–25, 2025 (ICH Day on May 22) 

Novotech will participate in the 2025 DIA China Annual Meeting, one of Asia’s most prominent life sciences conference. This event brings together over 5,000 professionals from more than 30 countries, facilitating multidisciplinary discussions across the entire drug development lifecycle—from discovery to post-marketing. 

As a regular participant, Novotech will be available to engage with sponsors seeking regional insights, operational expertise and support in in navigating the evolving clinical and regulatory landscape. 

Meet our representatives: 

• Andy Liu, Head of Novotech China.
• Michael Stibilj, Chief Operations Officer.
• David Ng, VP of Biometrics.
• Xiaoming Zhang, VP Head of Business Development - China.
• Senthil Raj, Head of Data Management
• Jannie Strydom, Director Biometrics Services and Innovation 

Featured Presentation: 

• Speaker: Jieli Hu
• Topic: Focus on the "Nuclear Missiles" in Pharmaceuticals — Radionuclide Drug Conjugates: Insights from Clinical Trial Audits 

Schedule a meeting through the form on this page or visit us at Booth J08 to connect with our team and explore how Novotech’s regional expertise and global capabilities can advance your clinical trial goals. 

Event info: DIA China 2025